194
Diagnostic medical technologies that detect microclots linked to Long COVID and measure inflammation, for patients, clinics, and partner labs in South Africa and beyond.
Biocode is a medical technology company serving patients, clinicians, and diagnostic partners with inflammation-focused testing, including microclot detection for Long COVID and rapid inflammation screening.
Key capabilities include:
Available via clinical testing services, with results provided to referring doctors (specific app or device platforms not listed).
Target users include patients with Long COVID or persistent inflammation symptoms seeking testing via healthcare providers, plus labs, clinics, and international partners looking to offer or license microclot diagnostics.
Notable in the South African market as a Stellenbosch University spinout (originating from collaboration between the university’s Physiology and Engineering departments) commercializing locally developed diagnostic methodologies and rapid tests, with operations based in Stellenbosch and testing access in South Africa.
Reviews reflect the personal opinions of users. Companies are not able to pay to alter or remove reviews. Verified reviews indicate the reviewer submitted proof of product usage. Learn how reviews work.
No reviews yet. Be the first to review this product.
Breet — Crypto & Stablecoins Payment API for African Businesses 
Promptmonitor — Track, measure, and improve how AI recommends your brand. 
Promptmonitor